The Surgical Experience and Treatment Options for Hepatic Cystic Disease
The Survival Benefits of Using Marginal Allografts in Liver Transplantation
The Trifecta Study: Calibrating Circulating Donor-Derived Cell-Free DNA at the Time of Indication Biopsies Against the Molecular Phenotype of the Biopsy Reveals a Prominent Association with NK Cell Genes
The Unintended Financial Consequences of Acuity Circles for Liver Allocation – Two-fold Increase in Import Fees and Higher Organ Acquisition Cost Despite Unchanged Travel Patterns
The Use of Donor Derived Cell Free DNA in Children to Monitor Therapy of Kidney Rejection
The Use of Hcv Nat+ Organs in Hcv Negative Recipients with On-site Specialty Pharmacy Services: A Win for the Patient, the Transplant Center, and Society?
The Use of Organs from Donors That Do Not Meet Eligibility Criteria in the United States
The Utility of PET/ CT Testing in Cardiac Risk Stratification of Adult Liver Transplant Candidates
Therapeutic Enoxaparin Dosing in Lung Transplant Recipients
Therapeutic Response of Late Clinical Cell Mediated Rejection is Modeled by Chronicity Changes
- « Previous Page
- 1
- …
- 104
- 105
- 106
- 107
- 108
- …
- 115
- Next Page »